17-Mar-2026
Market Chameleon (Mon, 16-Mar 4:43 AM ET)
Healthpeak Properties's Janus Living seeks to raise ~$731M through IPO
Seeking Alpha News (Mon, 16-Mar 8:00 AM ET)
Healthpeak Properties and Janus Living Announce Launch of Janus Living Initial Public Offering
Business Wire (Mon, 16-Mar 6:44 AM ET)
Business Wire (Fri, 27-Feb 5:30 PM ET)
Healthpeak's Strategic Moves Signal Focus on Senior Housing and Life Science Real Estate
Market Chameleon (Tue, 3-Feb 3:52 AM ET)
Healthpeak Properties Provides Strategic Initiatives Update and Reports Fourth Quarter 2025 Results
Business Wire (Mon, 2-Feb 4:15 PM ET)
Healthpeak Advances AI-Enabled Operating Platform, Naming Omkar Joshi Head of Enterprise Innovation
Business Wire (Wed, 21-Jan 4:15 PM ET)
Healthpeak Properties Announces Tax Treatment of 2025 Distributions
Business Wire (Thu, 15-Jan 4:15 PM ET)
Healthpeak Properties Announces $925 Million of Transaction Activity
Business Wire (Mon, 12-Jan 6:59 AM ET)
Business Wire (Fri, 9-Jan 4:15 PM ET)
Healthpeak owns a diversified healthcare portfolio of approximately 700 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
Healthpeak Properties trades on the NYSE stock market under the symbol DOC.
As of March 17, 2026, DOC stock price climbed to $17.65 with 9,271,475 million shares trading.
DOC has a beta of 0.48, meaning it tends to be less sensitive to market movements. DOC has a correlation of 0.11 to the broad based SPY ETF.
DOC has a market cap of $12.27 billion. This is considered a Large Cap stock.
Last quarter Healthpeak Properties reported $719 million in Revenue and $.47 earnings per share. This beat revenue expectation by $26 million and exceeded earnings estimates by $.25.
In the last 3 years, DOC traded as high as $23.26 and as low as $10.52.
The top ETF exchange traded funds that DOC belongs to (by Net Assets): VNQ, VTI, VOO, VB, VBR.
DOC has underperformed the market in the last year with a return of -8.3%, while SPY returned +20.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in DOC shares. However, DOC has outperformed the market in the last 3 month and 2 week periods, returning +9.7% and +0.1%, while SPY returned -0.9% and -2.3%, respectively. This indicates DOC has been having a stronger performance recently.
DOC support price is $16.96 and resistance is $17.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOC shares will trade within this expected range on the day.